Paradigm BioCapital Advisors LP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:02 pm Purchase | 2025-12-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Paradigm BioCapital Advisors LP | 6,541,210 6.200% | 1,802,281 (+38.03%) | Filing |
| 2025-02-03 4:36 pm Purchase | 2025-01-27 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Paradigm BioCapital Advisors LP | 4,738,929 5.000% | 4,738,929 (New Position) | Filing |